Saffier Drugs Private Limited - Company Profile

It is a food and beverages private limited company based in Chennai, Tamil Nadu, India, established in 2019.
2019 Chennai, Tamil Nadu, India Active
Last Updated:
Access Report
About Saffier Drugs Private Limited

Saffier Drugs Private Limited, a active private limited company, was established on 30 May 2019 in Chennai, Tamil Nadu, India. Engaging in artificial fibres within the food and beverages sector, it holds CIN: U24304TN2019PTC129628. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.56 M.

Its leadership includes Packia Swaminathan Prakash (Director), Muthukaruppan Palaniappan (Director), Ramu Veerappan (Director). Past directors included Muthukaruppan Palaniappan, Ramaswamy Vasudevan, Ramu Veerappan. Its latest AGM occurred on 30 August 2025, with the balance sheet filed on 31 March 2025. It is based at Kumaran Kudil, New No. 24/Old No. 25 Loganathan Nagar 1St Street, Choolaimedu, Chennai, Tamil Nadu, 600094.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24304TN2019PTC129628

  • Registration Number

    129628

  • Incorporation Date

    30 May 2019

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.56 M

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.56 M
  • Company Age 6 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** %
  • Profit Growth **** -88.40%
  • Ebitda **** -81.43%
  • Net Worth -101.13%
  • Total Assets -80.48%
Company report

Saffier Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Saffier Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Saffier Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Packia Swaminathan Prakash Director 30 May 2019 Current
Muthukaruppan Palaniappan Director 11 Feb 2021 Current
Ramu Veerappan Director 04 Mar 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 22 Sep 2021 Past
Pramod Abcsdd Director 11 Feb 2021 Past
Pramod Abcsdd Additional Director 19 Jun 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Saffier Drugs.

Saffier Drugs Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 88.4% decrease in profit. The company's net worth observed a substantial decline by a decrease of 101.13%.

Saffier Drugs revenue growth over time
Saffier Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -80.48%
*******
*******
*******
*******
Profit or Loss
*******
 -88.40%
*******
*******
*******
*******
Net Worth
*******
 -101.13%
*******
*******
*******
*******
EBITDA
*******
 -81.43%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Saffier Drugs?

Unlock access to Saffier Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Saffier Drugs?

Unlock and access historical data on people associated with Saffier Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Saffier Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saffier Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Saffier Drugs
Recent Activity within the Organization
  • Annual General Meeting

    The activity Saffier Drugs Private Limited last Annual general meeting of members was held on 30 Aug 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Saffier Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was recorded as a recent event.

  • Director Appointment

    Progress on Ramu Veerappan was appointed as a Director was appointed as a Director on 04 Mar 2025 & has been associated with this company since 11 months 27 days . was documented.

  • Director Appointment

    Muthukaruppan Palaniappan was appointed as a Director was appointed as a Director on 11 Feb 2021 & has been associated with this company since 5 years 17 days . was recorded as a recent event.

  • Director Appointment

    Packia Swaminathan Prakash was appointed as a Director was appointed as a Director on 30 May 2019 & has been associated with this company since 6 years 9 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Saffier Drugs Private Limited was registered on 30 May 2019 with Roc Chennai & aged 6 years 9 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Saffier Drugs Private Limited?

The CIN of Saffier Drugs Private Limited is U24304TN2019PTC129628.

Where is Saffier Drugs Private Limited headquartered?

Saffier Drugs Private Limited is headquartered at Kumaran Kudil, New No. 24/Old No. 25 Loganathan Nagar 1St Street, Choolaimedu, Chennai, Tamil Nadu, 600094.

When was Saffier Drugs Private Limited incorporated?

Saffier Drugs Private Limited was incorporated on 30 May 2019.

Who are the current directors of Saffier Drugs Private Limited?

The current directors of Saffier Drugs Private Limited are

What is the primary industry of Saffier Drugs Private Limited?

The primary industry of Saffier Drugs Private Limited is Food And Beverages.

Is Saffier Drugs Private Limited a listed company?

Saffier Drugs Private Limited is unlisted.

What is the capital structure of Saffier Drugs Private Limited?

The authorized capital of Saffier Drugs Private Limited is ₹1.00 M, and the paid-up capital is ₹0.56 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available